Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal That Empowers Tissue Damage.
The mechanisms that modulate the response to tissue injury are not fully understood. Abnormalities in the repair response are associated with a variety of chronic disease states characterized by inflammation, followed subsequently by excessive extracellular matrix (ECM) deposition. As cell-matrix interactions is able to regulate cellular homeostasis, modification of ECM integrity appears to be an unspecific factor in promoting the onset and progression of inflammatory diseases. Evidence is emerging to show that endogenous ECM molecules supply signals to damaged tissues and cells in order to promote further ECM degradation and inflammation progression. Several investigations have been confirmed that hyaluronan (HA) fragments of different molecular sizes exhibit different biological effects and responses. In fact the increased deposition of HA into the ECM is a strong hallmark of inflammation processes. In the context of inflammatory pathologies highly polymerized HA is broken down into small components which are able to exacerbate the inflammatory response by inducing the release of various detrimental mediators such as reactive oxygen species, cytokines, chemokines and destructive enzymes and by facilitating the recruitment of leukocytes. However, strategies involving the modulation of the HA fragment with specific receptors on cell surface could represent different promising effects for therapeutic scope. This review will focus on the inflammation action of small HA fragments in recent years obtained by in vivo reports.